Inhibition of the STAT3 target SGK1 sensitizes diffuse large B cell lymphoma cells to AKT inhibitors

Authors:

Abstract
No abstract available
Funding Information
  • U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (R01 CA187299, R01 CA187299, R01 CA187299, R01 CA187299, R01 CA187299, R01 CA187299, R01 CA187299)

This publication has 15 references indexed in Scilit: